One of Elon Musk’s DOGE Staffers Used to Sell Ketamine Professionally

Q: How long will it take to read this news story?

The story "One of Elon Musk’s DOGE Staffers Used to Sell Ketamine Professionally" has 636 words across 23 sentences, which will take approximately 3 - 6 minutes for the average person to read.

Q: Which news outlet covered this story?

The story "One of Elon Musk’s DOGE Staffers Used to Sell Ketamine Professionally" was covered 20 hours ago by Futurism, a news publisher based in United States.

Q: How trustworthy is 'Futurism' news outlet?

Futurism is a fully independent (privately-owned) news outlet established in 1997 that covers mostly technology news. The outlet is headquartered in United States and publishes an average of 7 news stories per day. It's most recent story was published 16 hours ago.

Q: What do people currently think of this news story?

The sentiment for this story is currently Neutral, indicating that people are not responding positively or negatively to this news.

Q: How do I report this news for inaccuracy?

You can report an inaccurate news publication to us via our contact page. Please also include the news #ID number and the URL to this story.<ul><li>News ID: #26050776</li><li>URL: https://beamstart.com/news/one-of-elon-musks-doge-17392221106917</li></ul>

Futurism 20h ago

One of Elon Musk’s DOGE Staffers Used to Sell Ketamine Professionally - Futurism

Quick Summary:

As the staff of Elon Musk's Department of Government Efficiency (DOGE) makes headlines for moving fast and breaking things, a deeper look into their backgrounds reveals that one used to hawk the billionaire's favorite drug for a living.

As the Washington Post reports, 36-year-old DOGE lackey Alexandra Beynon previously spent her days as head of engineering at the online ketamine therapy company Mindbloom before being shipped off to meddle at the Department of Education.

Mindbloom wasn't named in that study, but APN CEO Noah Nordheimer suggested that companies in the at-home psychedelic space "far too often take a backseat when it comes to the therapy aspect, often leaving patients to fend for themselves".